Beth Beaudet

Publications

452

Citations

H-Index

2001

Active since

Affiliations

Swiss Tropical and Public Health Institute(Current)

Drugs for Neglected Diseases Initiative

Scynexis (United States)

Pace University

Beth Beaudet is an author at Swiss Tropical and Public Health Institute specializing in drug discovery, signal transduction, and cellular biochemistry.

Top concepts

MedicineCell BiologyPharmacologyCell SignalingDrug DiscoveryCell PhysiologySignal TransductionCellular Biochemistry

Publications per year

2001–2011

Publications

SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis

Robert T. Jacobs, Bakela Nare, Stephen A. Wring et al. · PLoS neglected tropical diseases · 2011 · 294 citations · Full text

Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African Trypanosomiasis

Bakela Nare, Stephen A. Wring, Cyrus J. Bacchi et al. · Antimicrobial Agents and Chemotherapy · 2010 · 102 citations · Full text

Inhibition of Tumor Necrosis Factor-α (TNF-α) Production and Arthritis in the Rat by GW3333, a Dual Inhibitor of TNF-α-Converting Enzyme and Matrix Metalloproteinases

James G. Conway, Robert Andrews, Beth Beaudet et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 39 citations

Lysosomes Contribute to Anomalous Pharmacokinetic Behavior of Melanocortin-4 Receptor Agonists

Yuping Gong, Zhiyang Zhao, Donavon J. McConn et al. · Pharmaceutical Research · 2007 · 17 citations

Melanocortin-4 Receptor Agonists, Drug Target, Signal Transduction +10

Rows per page

1–4 of 4